Genomic Profiling of Mitochondrial Disease - Imaging Analysis for Precise Mitochondrial Medicine

CompletedOBSERVATIONAL
Enrollment

9

Participants

Timeline

Start Date

May 1, 2022

Primary Completion Date

January 22, 2024

Study Completion Date

January 22, 2024

Conditions
Mitochondrial MyopathiesMitochondrial DNA MutationMitochondrial DiseasesChronic Progressive External Ophthalmoplegia With MyopathyKearns-Sayre Syndrome
Trial Locations (1)

55901

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Casimir, LLC

UNKNOWN

collaborator

Astellas Pharma Inc

INDUSTRY

lead

Mayo Clinic

OTHER

NCT05012358 - Genomic Profiling of Mitochondrial Disease - Imaging Analysis for Precise Mitochondrial Medicine | Biotech Hunter | Biotech Hunter